1. Isolated perfused rat kidneys were used to study the effects of plasma fractions obtained by gel filtration from essential hypertensive patients ( n = 40) and from normotensive subjects ( n = 36) on resistance vessels. Perfusion pressure was recorded at a constant flow.
INTRODUCTION
The role of humoral factors in the pathogenesis of primary hypertension is currently being discussed. Early evidence in hypertensive rats stems from parabiosis experiments in Dahl salt-sensitive and salt-resistant rats [ 1-31 and in spontaneously hypertensive rats (SHR) [4] . More recently, the humoral transmission of hypertension from SHR to normotensive rats was demonstrated by parabiosis and cross-circulation experiments [5-81. Humoral factors may also account for structural vascular changes usually found in hypertension. As Greenberg et al. [4] demonstrated by parabiosis experiments performed between SHR and normotensive Wistar-Kyoto rats (WKY ), portal veins obtained from WKY after parabiosis showed similar increased contractility, decreased extensibility and hypertrophy to the portal veins from SHR in the hypertensive state.
Several groups have assessed the activity of a circulating factor sensitizing to pressor agents such as noradrenaline (NA) and angiotensin I1 (ANG 11) in animal models of hypertension. A vasopressor potentiator to NA was found in the serum of salt-induced hypertensive rats [9] and in the serum of SHR [lo] . A similar substance could be demonstrated in plasma of dogs with renovascular hypertension [ 11, 121, in hypertensive Dahl salt-sensitive rats [13] and in SHR [14] . In some experiments, the detected substances were shown to increase blood pressure in a nephrectomized normotensive rat [ 1 1-131.
A substance sensitizing to pressor agents has also been described in human hypertension. Such a substance has been detected in essential hypertension [15, 161, malignant hypertension [ 1 11 and renovascular forms of hypertension [ 171. In essential hypertension, recent experiments indicated the presence of a yet unidentified circulating vasopressor agent [ 181. After intravenous injection of plasma fractions from essential hypertensive patients, the blood pressure of an anaesthetized normotensive rat increased significantly. By adding ['HIANG I1 to a sample of plasma before gel filtration, it was demonstrated that this effect was not due to ANG 11, because ANG I1 was not detected in the plasma fraction which elicited the maximum rise in blood pressure [ 181.
In this study we examined whether the pressure substance characterized by intravenous injection in the intact animal directly acts on resistance vessels of an isolated perfused rat kidney.
MATERIALS AND METHODS

Experiments in rats
The experiments were performed in normotensive WKY weighing 300-400 g which were anaesthetized with 1.4 g of urethane/kg body weight administered intraperitoneally. Mean arterial pressure was monitored through a plastic catheter inserted into the common carotid artery using a Statham element. The plasma fractions were administered intravenously through a central venous catheter inserted through the external jugular vein. To avoid major changes in blood volume, each sample injected had a volume of 0.5 ml. Not more than six fractions were tested in one rat. Between the injections a recovery period of 1 0 min was allowed. In the experiments with the isolated perfused kidney, the fractions used were those which had been found to increase blood pressure when injected intravenously in the rat, and the analogous normotensive fractions.
Preparation of the isolated perfused rat kidney
Four-to six-week-old normotensive WKY were anaesthetized with urethane ( 1.4 g/kg body weight, intraperitoneally). The abdominal cavity was opened by a midventral incision. The aorta and the left kidney were carefully isolated from adhesive tissue by blunt dissection. Ligatures were placed around the left renal artery and the infrarenal aorta. A polyethylene catheter was placed in the distal aorta. Immediately after the insertion of the catheter, 5 0 0 units of heparin sodium were injected. Then perfusion was started. The catheter was gently advanced into the left renal artery without interruption of flow. The kidney was excised and immediately mounted in the perfusion system.
Perfusion system
The perfusion procedure generally followed the description given by Hofbauer et ul. [19] . Briefly, the isolated rat kidney was perfused by means of a peristaltic pump in a single-pass system with a solution containing 1 1 5 mmol/l NaCI, 4.6 mmol/l KCI, 1 mmol/l CaCI,, 1.2 mmol/l MgSO,, 1.2 mmol/l NaH,PO,, 22 mmol/l NaHCO,, 49 mmol/l glucose and 35 g of gelatine/l (Haemaccel; Behringwerke, Marburg, F.R.G.), and equilibrated with 95"/0 0 , / 5 X , CO,. The perfusion medium and the kidney were kept at 37°C. Perfusion flow was constant at 8-9 ml/min. Perfusion pressure was continuously monitored by a transducer (Gould P 23) connected to a bridge amplifier (Hugo Sachs, Freiburg, F.R.G.). After an equilibration period of 30 min, plasma fractions and vasoactive hormones, e.g. ANG 11, were injected in bolus injections of 0.1 ml. Only plasma fractions from single patients were tested. ANG I1 was injected in concentrations of 0.5-10 ng/O.l ml. In four experiments, isolated perfused kidneys were used after administration of 1 mg of reserpine 18 h previously. Tyramine (10-' g) was injected to control the effect of chemical denervation.
Preparation of plasma fractions
Forty plasma samples from essential hypertensive patients (age 44.8k25.3 m e a n f s~, 24 males, 16 females) and 36 samples from normotensive subjects (age 4 1.2 f 22.6 mean f SD, 20 males, 16 females) were used for the experiments. In the isolated perfused kidney, samples equivalent to 60 ml of plasma were tested. In the hypertensive patients diagnosis of essential hypertension was established after exclusion of secondary forms of hypertension by the appropriate clinical, radiological and laboratory examinations (digital subtraction angiography of renal arteries, 24 h urinary catecholamines and cortisol, plasma aldosterone and renin activity). The patients studied had not received antihypertensive drugs previously. Their blood pressure (systolic/diastolic) was 1 8 7 f 17/121 k 10 mmHg (meanksD). The blood pressure of the normotensive subject was 124 k 13/84 k 9 mmHg.
The samples were prepared as described by Zidek et al. [20] . Briefly, plasma samples were first precipitated with methanol. The supernatant was dialysed for 24 h to remove substances with a molecular mass greater than 3500 Da, using dialysis tubes (Spectra Por 6 MWCO 3500; Fa. Reichelt, Munster, F.R.G.). Thereafter salt was removed by ultrafiltration with membranes permeable to substances with a molecular mass lower than 5 0 0 Da (Amicon YC; Amicon, Witten, F.R.G.). Remaining substances were separated roughly according to their molecular mass by gel chromatography using Biogel p2. Several peaks could be identified by U.V. spectrometry at 280 nm. U.V. indicated that several fractions were formed from the eluate. These fractions were then concentrated to 0.5 ml by freeze-drying. Furthermore, the Na+ and K' content, pH and osmolality of the final samples were measured in order t o avoid unspecific effects on blood pressure o r perfusion pressure due to deviations of Na+ and K + content and osmolality from the physiological range. Osmolality was maintained between 280 and 320 mosmol/l with Na' concentration of I 00-120 mmol/l and K' concentration below 6 mmol/l. pH was between 7.55 and 7.2. The fractions were administered to a normotensive rat as described previously [ 181. Thc fraction which induced the maximum rise in blood pres-
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sure and the analogous fraction from normotensive blood were used for further experiments in the isolated perfused rat kidney. In 10 experiments, nifedipine was added to the perfusion medium ( mol/l, n = 5). In five experiments the active fraction from hypertensive plasma was incubated with trypsin (2 units/ml, bovine pancreas, type XIII, Sigma) for 12 h at 25°C. Thereafter the enzyme was separated from the compounds of the plasma fraction by ultrafiltration of substances < 10000 Da with Centricon tubes (Amicon), and the trypsintreated fraction was tested in the isolated perfused kidney together with an untreated sample. In 12 experiments, saralasin was present in concentrations of and mol/l, and in 11 other experiments, the perfusion medium contained lo-', lo-' and lo-' mol/l phentolamine. Four experiments were performed in Ca*+-free solution containing 2 mmol/l ethyleneglycol bis-( aminoethyl ether)tetra-acetate (EGTA). To test the effect of adenosine triphosphatase ( ATPase) inhibition, ouabain was added to the perfusion medium in concentrations of 0.1,0.5 and 1 mmol/l.
For statistical evaluation of the data, Student's t-test for paired data and Wilcoxon's test were used; P values of less than 0.05 were considered to be significant.
Measurement of Na+ -K+ ATPase activity
Na+ -K+-ATPase inhibition was measured by the procedure of Hamlyn et al. [21] . Principally, in this assay the regeneration of enzymatically hydrolysed adenosine 5'-triphosphate is coupled to the oxidation of nicotinamide-adenine dinucleotide (reduced), so that the rate of adenosine 5'-triphosphate turnover can be monitored by recording the absorbance of nicotinamide-adenine dinucleotide (reduced) at 340 nm.'Inhibition of Na+-K+-ATPase activity after addition of a plasma fraction was expressed as the percentage of the enzyme activity obtained after addition of saline (150 mmol/l NaCI). Na+ -K+-ATPase from canine kidney was obtained from Sigma and had an activity of 5-6 mmol/l min-' mg-' of protein. The ouabain-insensitive Mg2 + ATPase activity was less than 2% of the total ATPase activity. mol/l, n = 5; Fig. 1 shows the effect of intravenous injection of plasma fractions obtained by gel chromatography on the mean arterial pressure of a normotensive rat. One fraction of hypertensive plasma containing substances of 1 -1.5 kDa caused a pronounced increase in blood pressure, whereas the analogous normotensive fraction elicited either no increase or a modest increase in blood pressure (Fig. 1 ) . The increase in blood pressure after intravenous injection of an active hypertensive plasma fraction lasted about 10-15 min. Maximum responses were obtained after administration of fractions equivalent to 80 ml of plasma. By this procedure the hypertensive plasma fractions used for experiments in the isolated perfused kidney were shown to be active. Table 1 shows the responses of the isolated perfused kidney to ANG 11 and NA. The increase in perfusion pressure induced by 80 mmol/KCI could be prevented by the addition of nifedipine ( lo-' mol/l). Effects of plasma fractions. When plasma fractions from essential hypertensive patients which had been shown to induce a blood pressure rise in the intact rat were injected into the perfusion system, a transient increase in perfusion pressure of 20 k I7 mmHg (range 5-58 mmHg, n = 4 0 , 1-'<0.0001, Fig. 2 ) was induced.
RESULTS
Experiments in rats
Maximum contraction was reached after about 1 min. Subsequently, the perfusion pressure declined to baseline values after 4-22 min. Fig. 3 shows the effect of various concentrations of the active fraction on perfusion pressure. The changes in perfusion pressure were dependent on the concentration of the active fraction. Tachyphylaxis was not observed during repetitive applications of this fraction. Heating the fractions to 100°C for 10 min did not affect the vasoconstrictor activity. The analogous normotensive fraction caused an increase in perfusion pressure of 3 f 3 mmHg, which is significantly less than the response to the hypertensive fraction (P<0.01). For comparison, the effects of NA and ANG I1 in various concentrations are shown in Table 1 . In 23 of 40 samples, equal amounts of the active plasma fractions were tested in both the isolated perfused kidney and in the intact rat. There was a correlation coefficient of r=0.79 between the effects in both preparations (Fig. 4) . Fig. 5 shows the profile of the response to the fractions obtained by chromatography in relation to the chromatographic pattern. Fig. S(a) displays the changes in perfusion pressure induced by the fractions labelled on the abscissa. In Fig. 5 ( b ) the absorbance at 280 nm and the conductivity are shown. Active fractions from hypertensive plasma pretreated with trypsin showed similar effects to the untreated fractions, with a mean increase in perfusion pressure of 87.4 f 12.6%) of the untreated 10 min 
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. Fig. 6 . Changes in perfusion pressure in the isolated kidney at constant flow after administration of samples of 0.1 ml of an active plasma fraction from essential hypertensive patients (HF) before and after addition of nifedipine (lo-" and mol/l) to the perfusion medium, and in Ca2+-free medium containing 2 mmol/l EGTA. For comparison, the effect of ANG I1 (1 ng) on the perfusion pressure of the isolated perfused kidney is shown. control sample. The active plasma fraction did not inhibit Na+-K+ -ATPase activity.
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Effects of drugs on the response to the hypertensive factor. Addition of nifedipine in concentrations of mol/l and lo-' mol/l to the perfusion medium reduced the response of the kidney to the hypertensive fractions by 35.3 f 12.4% and 66.5 f 18.2% (P<0.05), respectively (Fig. 6) . When Ca2+ in the perfusion medium was replaced by 2 mmol/l EGTA, the response to active plasma fractions was reduced by 95.2 k 6.3% ( P < 0.05; Fig. 3 ). On perfusion with a solution containing phentolamine mol/l), the response of the kidney to active fractions was not significantly changed (Fig. 7) . The same results were obtained with phentolamine concentrations Pretreatment with reserpine did not abolish the response to the active hypertensive plasma fraction (Fig. 9) . Perfusion with ouabain caused a transient increase in perfusion pressure. After an initial increase, the perfusion pressure returned to baseline values within 20 min. The maximum increase in the perfusion pressure was 4 f 1, 1 9 k 7 and 4 2 k 1 5 mmHg with 0.1, 0.5 and 1 mmol/l ouabain, respectively (Fig. 10) . There was no significant correlation between vasopressor activities of the hypertensive plasma samples and casual blood pressure of the patients ( I = 0.24).
DISCUSSION
In a previous study, a factor circulating in the blood of essential hypertensive patients which caused an increase in blood pressure of normotensive rats after intravenous injection was demonstrated [18] . There are several possibilities for the underlying mechanisms of the rise in blood pressure observed: first, a direct vasopressor action of the substance on vascular smooth muscle; secondly, indirect mechanisms such as activation of other hormones or of the sympathetic nervous system; and thirdly, positive inotropic effects and an increased cardiac output might be responsible for the pressor activity of the factor. In this study, the isolated perfused rat kidney of a normotensive rat was used as a model to examine the effects of the aforementioned plasma fractions on vascular smooth muscle directly. This model offered the advantage that the small peripheral arteries which are mainly responsible for the vascular resistance could be studied. The results obtained in this study show that the same fraction from the plasma of essential hypertensive patients which increased blood pressure in the intact animal, induced a significant rise in vascular resistance of the isolated perfused rat kidney. Whether additional positive inotropic effects or an activation of the sympathctic nervous system might contribute t o the rise in blood pressure induced by the substance in the intact animal cannot he deduced from the results of this study. The effects of the hypertensive plasma fractions o n the perfused rat kidney cannot be attributed to enhanced concentrations o f activators of a-adrenoceptors o r ANG I1 in these fractions, since the a-adrenoceptor blocker, phentolamine, or saralasin, a competitive antagonist of ANG 11, did not reduce constriction of the perfused renal vasculature. Furthermore, the normotensive fractions analogous to the active hypertensive fractions did not exhibit vasopressor activity. Therefore in normotensive plasma, the agent either may not be present or may only be present in markedly reduced concentrations compared with hypertensive plasma.
The vasopressor action of the substance was shown to depend on extracellular Ca? +. Among other factors, cytoplasmic free Ca?+ is known to regulate the contractile activity of vascular smooth muscle [22] . Principally, an elevation in cytoplasmic Ca2 + concentration can result from either a release of Ca?+ from the endoplasmic reticulum and other cellular Ca2 + stores or a Ca2+ influx from the extracellular fluid, or from both. Since the vasopressor effect of the substance was almost abolished by Ca' + -free, EGTA-containing solutions, its action seems to be mediated mainly by Ca2+ influx. As the vasopressor action of the factor is not abolished, but only reduced, by addition of nifedipine to the perfusion medium, it is possible that only pressure-dependent vasoconstriction 123, 241, which may be superimposed on the action of the hypertensive factor, but not the direct effect of the factor was blocked by nifedipine. Thus a role of the nifedipinesensitive, voltage-dependent Ca?
+ channels for the effect of the hypertensive factor cannot be assumed definitely. Instead, the hypertensive factor may act by opening receptor-operated or non-specific Ca? + channels. In essential hypertension, elevated levels of intracellular Ca" have been detected 125-281. This may be due either to an inherited defect of intracellular Ca?+ metabolism or to the action of a hormone. Several groups have presented evidence for substances in the blood of essential hypertensive patients affecting Ca'+ metabolism. Lindner et u/. [29] demonstrated an increase in cytosolic Ca2+ in platelets from normotensive subjects when they were incubated with plasma ultrafiltrates from hypertensive subjects. Zidek er ul. [6] found an increased intracellular Ca" concentration in porcine aortic smooth muscle cells incubated in hypertensive plasma compared with those incubated in normotensive plasma. If in plasma from essential hypertensive patients, a substance was present inducing an enhanced intracellular Ca? + concentration in arteriolar smooth muscle cells, this might result in the increased vascular resistance which is the hallmark of essential hypertension.
I t was postulated that the observed increase in intracellular Ca' 31 I. According to de Wardener and co-workers 132, 331, the increased intracellular Na+ concentration is caused by the so-called natriuretic hormone inhibiting the activity of Na+-K+-ATPase in a similar manner t o the action of ouabain. Whether the vasoconstrictor demonstrated in this study shows any relationship to the natriuretic hormone is not clear. However. preliminary results showed that substances inhibiting Na+-K+-ATPase were separated from the hypertensive factor by gel chromatography. Furthermore, direct vasopressor actions of the natriuretic hormone have not yet been shown.
The experiments with ouabain showed that in the isolated perfused rat kidney inhibition of Na+-K+-ATPase induced vasoconstriction. However, it is known that the vasoconstriction induced by higher concentrations of ouabain, e.g. mol/l, is partly due to release of NA [34] .
In summary, a substance with direct vasopressor activity was found in plasma from essential hypertensive patients. It was demonstrated that it probably does not act as an a-adrenoceptor agonist or as an activator of ANG I1 receptors. Since its action depends on extracellular Ca*+, it is likely that it acts by stimulation of Ca2+ influx from the extracellular space.
